Researchers at The University of Texas at Arlington have found a potential new pathway to regulate immune response and potentially control inflammatory diseases of the central nervous system such as meningitis and sepsis.
“We need to know what turns on inflammatory response to bacterial infection to be able to modulate the process,” said Subhrangsu Mandal, the UTA associate professor of chemistry who led the research.
“If we can do so, we can control inflammatory diseases of the central nervous system that have been hard to treat up to now, such as sepsis and meningitis, as well as cancer and muscular dystrophy, which can also be seen a kind of inflammation,” he added.
Mandal and his team’s research findings were published in Scientific Reports.
The researchers have found that the long non-coding RNA molecule HOTAIR present in white blood cells has the capacity to signal these cells to activate immune response in the presence of bacteria. RNA, or ribonucleic acid, is present in all living cells. Its primary role is to carry instructions from DNA.
“Knowing that HOTAIR has a role in the signaling pathway also means that we can use it as a biomarker for bacterial infection,” he added. “Simple blood tests could indicate infection much more quickly, enabling better treatment for patients of rapidly-moving diseases such as septic shock and meningitis, which have been hard to treat up to now.”
The researchers used the resources of UTA’s North Texas Genome Center to demonstrate that noncoding RNA expression – including HOTAIR – is induced in white blood cells treated with lipopolysaccharide, which are molecules found on the outer membrane of bacterial cells. The research showed that HOTAIR gene was expressed alongside cytokines, which are excreted by cells as part of immune response, and inflammatory response genes such as iNOS. As a result, it is possible to conclude that HOTAIR is a key regulator for pathogen-induced cytokine expression, immune response and inflammation.
“Long non-coding RNAs like HOTAIR are emerging as key regulators of cell signaling processes and many are expressed in immune cells and play a critical role in immune response,” Mandal said. “Previous research carried out with Marco Brotto in UTA’s College of Nursing and Health Innovation had already established a link between low flow of oxygen to tissues and HOTAIR, which has been linked to cancer.”
“Having a resource like the North Texas Genome Center really means that we can multiply our work looking at non-coding RNAs in general, a burgeoning field in biochemistry,” he added.
Fred MacDonnell, UTA chair of chemistry and biochemistry, congratulated Mandal on this new research.
“Basic science related to the pathways for immune response is critical as there have been very few successes up to now developing treatments for extreme inflammations like sepsis and meningitis, “ MacDonnell said.
The Latest on: Immune response
via Google News
The Latest on: Immune response
- COVID-19 Immune Response Appears Strong in Cancer Patientson August 23, 2021 at 7:37 am
The seropositivity rate among patients with cancer remains high four months after the second dose of the COVID-19 vaccine, according to a research letter published online Aug. 11 in JAMA Oncology .
- New study reveals unique immune responses to SARS-CoV-2, Ebola and respiratory syncytial virus using B cell repertoire analysison August 23, 2021 at 6:40 am
A new study has been published on the bioRxiv* preprint server, which takes a long-read repertoire amplification approach to better understand, compare and contrast B cell responses to emerging or ...
- Immune Response to COVID-19 May Be Proportional to Illness Severity, Durationon August 23, 2021 at 4:24 am
People who have had severe or long-lasting cases of COVID-19 are more likely to have high levels of an important antibody needed to fight against future infection, according to a Rutgers study.
- People get immune response after Covid: WHO scientiston August 22, 2021 at 7:27 pm
People get immune response after getting Covid, but it is always advisable to receive vaccination after recovery from the disease, a scientist said. ..
- F.D.A. to Authorize Third Vaccine Dose for People With Weak Immune Systemson August 20, 2021 at 3:14 pm
The decision to expand the emergency use of both the Pfizer-BioNTech and Moderna vaccines is meant to help transplant recipients and others whose immune systems are similarly compromised.
- Immune Response to COVID-19 May Be Tied to Illness Severityon August 20, 2021 at 10:01 am
One of your neighbors posted in Health & Fitness. Click through to read what they have to say. (The views expressed in this post are the author’s own.) ...
- SARS-CoV-2 lambda variant escapes immune response via spike mutationson August 20, 2021 at 4:54 am
A new study explores the mechanism by which the SARS-CoV-2 lambda variant has acquired immune evasion capabilities above that of the wildtype.
- Booster shot elicits strong immune response to delta variant, Pfizer tells FDAon August 17, 2021 at 1:29 pm
People who received a third dose of the Pfizer-BioNTech coronavirus vaccine elicited a stronger immune response to the delta variant compared to those who only completed the two-dose regimen, the ...
- Immune response to SARS-CoV-2 variants investigatedon August 16, 2021 at 6:56 am
HSE University researchers assessed the effectiveness of the T-cell immune response to 11 variants of SARS-CoV-2. The researchers used their results to develop the T-cell COVID-19 Atlas portal (T-CoV) ...
via Bing News